The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.
Vanguard Intranasal Rapid Resp 3 (Canada)This page contains information on Vanguard Intranasal Rapid Resp 3 for veterinary use.
The information provided typically includes the following:
- Vanguard Intranasal Rapid Resp 3 Indications
- Warnings and cautions for Vanguard Intranasal Rapid Resp 3
- Direction and dosage information for Vanguard Intranasal Rapid Resp 3
Vanguard Intranasal Rapid Resp 3This treatment applies to the following species:
Canine Adenovirus Type 2-Parainfluenza-Bordetella bronchiseptica Vaccine
Modified Live Virus & Avirulent Live Culture
NOT FOR INJECTION
For vaccination of healthy dogs 8 weeks of age or older as an aid in preventing respiratory disease caused by canine adenovirus Type 2 (CAV-2) virus, canine parainfluenza caused by canine parainfluenza (CPI) virus, and disease caused by Bordetella bronchiseptica.
Directions For Use
Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided and shake well. Draw contents back into the syringe, remove the needle and administer a single 0.5-mL dose intranasally. Annual revaccination with a single dose is recommended.
PrecautionsStore at 2°-7°C. Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency. Do not freeze. Use entire contents when first opened. Sterilized syringes should be used to administer this vaccine. Do not sterilize with chemicals because traces of disinfectant may inactivate the vaccine. Burn containers and all unused contents. Vaccination of pregnant bitches should be avoided. In case of anaphylactoid reaction, administer epinephrine.
Technical inquiries should be directed to Zoetis Inc. Veterinary Services, (888) 963-8471 (USA), (800) 461-0917 (Canada).
U.S. Veterinary License No. 190
Zoetis Inc., Kalamazoo, MI 49007, USA
25 1-dose vials of vaccine, rehydrate each to 0.5 mL
25 0.5-mL vials of sterile diluent
|Every effort has been made to ensure the accuracy of the Vanguard Intranasal Rapid Resp 3 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-09-29